BRAF and acral lentiginous melanoma: Median OS was 18.5 months (95% CI, 10.4–28.8) and 5.8 months (95% CI, 0.5–7.4) in patients with BRAF wild-type and BRAF-mutant acral melanoma, respectively (Table 4).